Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express GenesEnables nucleic acids therapeutics research, which can include antisense oligonucleotide therapies, gene therapies and more SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech customers’ pre-clinical studies.“Our new plasmid preps combine the quality and consistency needed for preclinical research with the speed and cost efficiency customers have come to expect from Twist,” said Emily M. Leproust, CEO and co-founder of Twist Bioscience. “By offering animal origin-free and transfection-grade preps, customers can rely on Twist from the early research and discovery stage through preclinical development, streamlining their supply chains and
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]Yahoo! Finance
- Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law FirmGlobeNewswire
- Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength [Seeking Alpha]Seeking Alpha
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- TWST's page on the SEC website